id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-006179-7uv4yfv2	Cheuk, Daniel Ka Leung	Autologous hematopoietic stem cell transplantation for high-risk brain tumors in children	2007-09-29		.txt	text/plain	4580	211	46	Autologous hematopoietic stem cell transplant (AHSCT) has been advocated as a form of salvage therapy for children with high-risk or relapsed brain tumors but only limited data are available currently. Over the past decade, high-dose chemotherapy with autologous hematopoietic stem cell transplant (AHSCT) has been tried in patients with high-risk brain tumors in an attempt to eradicate residual neoplastic cells and improve cure rate. In conclusion, AHSCT can result in long-term survival with satisfactory functional status in children with recurrent brain tumors, especially for those who can achieve complete remission before transplant. High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors	./cache/cord-006179-7uv4yfv2.txt	./txt/cord-006179-7uv4yfv2.txt